Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

Ana C Garrido-Castro, MD · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
hrmetastaticbreastcancer
invasive breast cancer, metastatic breast cancer, hr-positive breast cancer, her2-negative breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911541
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.